THOMAS JAMES DOYLE - 27 Jan 2023 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Signature
Teresa Bair, Attorney-in-fact for Thomas Doyle
Issuer symbol
KURA
Transactions as of
27 Jan 2023
Net transactions value
-$21,502
Form type
4
Filing time
31 Jan 2023, 16:14:39 UTC
Previous filing
09 Feb 2022
Next filing
21 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Sale $9,473 -682 -3.7% $13.89 17,707 27 Jan 2023 Direct F1, F2
transaction KURA Common Stock Sale $12,029 -866 -4.9% $13.89 16,841 27 Jan 2023 Direct F3
holding KURA Common Stock 500 27 Jan 2023 spouse's 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sell-to cover for taxes associated with the vesting of RSUs received by the Reporting Person dated 1/26/22.
F2 Includes 1,806 shares acquired on May 17, 2022 and 1,583 shares acquired on November 17, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.
F3 Sell-to cover for taxes associated with the vesting of RSUs received by the Reporting Person dated 2/7/22.